Abstract:ABSTRACT Acute pancreatitis (AP) is a type of digestive system disease with high mortality. Previous studies have shown that gut microbiota can participate in developing and treating acute pancreatitis by affecting the host’s metabolism. In this study, we followed 20 AP patients to generate longitudinal gut microbiota profiles and activity during disease (before treatment, on the third day of treatment, and 1 month after discharge). We analyzed species composition and metabolic pathways’ changes across the treatment phase, severity, and etiology. The diversity of the gut microbiome of patients with AP did not show much variation with treatment. In contrast, the metabolic functions of the gut microbiota, such as the essential chemical reactions that produce energy and maintain life, were partially reinstated after treatment. The severe AP (SAP) patients contained less beneficial bacteria (i.e., Bacteroides xylanisolvens , Clostridium lavalense, and Roseburia inulinivorans ) and weaker sugar degradation function than mild AP patients before treatment. Moreover, etiology was one of the drivers of gut microbiome composition and explained the 3.54% variation in species’ relative abundance. The relative abundance of pathways related to lipid synthesis was higher in the gut of hyperlipidemia AP patients than in biliary AP patients. The composition and functional profiles of the gut microbiota reflect the severity and etiology of AP. Otherwise, we also identified bacterial species associated with SAP, i.e., Oscillibacter sp . 57_20 , Parabacteroides johnsonii, Bacteroides stercoris, Methanobrevibacter smithii, Ruminococcus lactaris, Coprococcus comes, and Dorea formicigenerans , which have the potential to identify the SAP at an early stage. IMPORTANCE Acute pancreatitis (AP) is a type of digestive system disease with high mortality. Previous studies have shown that gut microbiota can participate in the development and treatment of acute pancreatitis by affecting the host’s metabolism. However, fewer studies acquired metagenomic sequencing data to associate species to functions intuitively and performed longitudinal analysis to explore how gut microbiota influences the development of AP. We followed 20 AP patients to generate longitudinal gut microbiota profiles and activity during disease and studied the differences in intestinal flora under different severities and etiologies. We have two findings. First, the gut microbiota profile has the potential to identify the severity and etiology of AP at an early stage. Second, gut microbiota likely acts synergistically in the development of AP. This study provides a reference for characterizing the driver flora of severe AP to identify the severity of acute pancreatitis at an early stage.

Significant Succession of Intestinal Bacterial Community and Function During the Initial 72 Hours of Acute Pancreatitis in Rats

Dynamic Changes of the Colonic Microbiota in Rat during Severe Acute Pancreatitis

Establishment of the Critical Period of Severe Acute Pancreatitis-Associated Lung Injury.

Comparative Study of Gut Microbiota and Metabolite Variations Between Severe and Mild Acute Pancreatitis Patients at Different Stages

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Composition and functional profiles of gut microbiota reflect the treatment stage, severity, and etiology of acute pancreatitis

Structural Shifts of Fecal Microbial Communities in Rats with Acute Rejection after Liver Transplantation

Early gut mucosal dysfunction in patients with acute pancreatitis

Bacterial community mapping of the intestinal tract in acute pancreatitis rats based on 16S rDNA gene sequence analysis

Intestinal microflora and metabolites affect the progression of acute pancreatitis (AP)

Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses

Altered gut microbiota in the early stage of acute pancreatitis were related to the occurrence of acute respiratory distress syndrome

Integrating metagenomics with metabolomics for gut microbiota and metabolites profiling in acute pancreatitis

Changes in permeability of intestinal mucosa in early phase of acute pancreatitis

Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice

Effects of Probiotics on Gut Microflora and Barrier Function of Rats with Acute Pancreatitis

Integrative Proteomics, Phosphoproteomics and Acetylation Proteomics Analyses of Acute Pancreatitis in Rats.

Dysbiosis of Intestinal Microbiota and Decrease in Paneth Cell Antimicrobial Peptide Level During Acute Necrotizing Pancreatitis in Rats

Gut Origin Sepsis, Macrophage Function, and Oxygen Extraction Associated with Acute Pancreatitis in the Rat

The crosstalk between microbiota and metabolites in AP mice: an analysis based on metagenomics and untargeted metabolomics

Gut microbiota on admission as predictive biomarker for acute necrotizing pancreatitis